Publications by authors named "Aurelien Jamotte"

Claim this Profile
A
A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in four European countries: Austria, Belgium, Greece, and Italy.
Evangelos Terpos, Aurelien Jamotte, Alexandra Christodoulopoulou, Marco Campioni, Debajyoti Bhowmik

J Med Econ· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK.
Emilie Clay, Aurélien Jamotte, Peter Verhamme, Alexander T Cohen, Ben A Van Hout

J Mark Access Health Policy· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of patient characteristics and treatment procedures on hospitalization cost and length of stay in Japanese patients with influenza: A structural equation modelling approach.
Rosarin Sruamsiri, Sameh Ferchichi, Aurélien Jamotte, Mondher Toumi, Hiroshi Kubo

Influenza Other Respir Viruses· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Public health impact and economic benefits of quadrivalent influenza vaccine in Latin America.
Aurélien Jamotte, Emilie Clay, Bérengère Macabeo, Andrès Caicedo, Juan Guillermo Lopez

Hum Vaccin Immunother· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of quadrivalent influenza vaccine on public health and influenza-related costs in Australia.
Aurélien Jamotte, Chui Fung Chong, Andrew Manton, Bérengère Macabeo, Mondher Toumi

BMC Public Health· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis